Keywords: Roche, Alzheimer's disease, Gantenerumab, Amyloid plaques

Roche's MAb gantenerumab seen to remove amyloid plaques from the brain of Alzheimer’s patients

Article | 12 October 2011

Print This

Swiss drug major Roche (ROG: SIX) says that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in